None listed
Conditions
Interventions
None listed
Sponsors
Keimyung University Dongsan Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Adult patients over 19 years of age. 2)Patients diagnosed with non-valvular atrial fibrillation atrial 3)Patients who are taking low-capacity Apixaban with anticoagulant therapy within the last six months of the date of consent in accordance with the drug manual , Patients who did not have a history of the primary and secondary evaluation variables, Clinical Event, or who are scheduled to take Apixaban after taking it 4) Patients with a CHA 2 DS2 VASc score of 2 or higher or male patients with a CHA 2 DS2 VASc score of 1 5) Patients who meet at least two of the three criteria below A. Cr = 1.5mg / B. age =80 years C. weight =60 kg
Exclusion criteria
Exclusion criteria: 1) Those vulnerable to clinical research (Follow KGCP definition)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incident rate of stroke or systemic embolism;Incident rate of major bleeding events | — |
Secondary
| Measure | Time frame |
|---|---|
| Exacerbation of heart failure;Mediation by heart event;death from any cause;Myocardial Infarction | — |
Countries
Korea, Republic of
Contacts
Public ContactSeongwook Han
Keimyung University Dongsan Hospital
Outcome results
None listed